US approves Ranbaxy's generic Biaxin antibiotic

By siliconindia staff writer   |   Monday, 27 September 2004, 19:30 IST
Printer Print Email Email
MUMBAI: Ranbaxy Laboratories Ltd has received the US Food and Drug Administration's approval for clarithromycin, a generic form of Abbott Laboratories Inc's antibiotic Biaxin, the FDA said on Saturday. Biaxin had sales worth $538 million in the US in 2003. Earlier this year, the FDA had approved generic Biaxin forms from Andrx Corp and Roxane Laboratories.